IL50817A0 - A 1,4-dihydropyridine-3,5-dicarboxylic acid di-ester derivative,its preparation and pharmaceutical compositions containing it - Google Patents

A 1,4-dihydropyridine-3,5-dicarboxylic acid di-ester derivative,its preparation and pharmaceutical compositions containing it

Info

Publication number
IL50817A0
IL50817A0 IL50817A IL5081776A IL50817A0 IL 50817 A0 IL50817 A0 IL 50817A0 IL 50817 A IL50817 A IL 50817A IL 5081776 A IL5081776 A IL 5081776A IL 50817 A0 IL50817 A0 IL 50817A0
Authority
IL
Israel
Prior art keywords
dihydropyridine
preparation
pharmaceutical compositions
dicarboxylic acid
compositions containing
Prior art date
Application number
IL50817A
Other versions
IL50817A (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL50817A0 publication Critical patent/IL50817A0/en
Publication of IL50817A publication Critical patent/IL50817A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL50817A 1975-11-05 1976-11-02 Isobutyl methyl-1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridine dicarboxylate,its preparation and pharmaceutical compositions containing it IL50817A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2549568A DE2549568C3 (en) 1975-11-05 1975-11-05 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl) -1,4-dihydropyridine-5-carboxylic acid isobutyl ester, several processes for its preparation and pharmaceuticals containing it

Publications (2)

Publication Number Publication Date
IL50817A0 true IL50817A0 (en) 1977-01-31
IL50817A IL50817A (en) 1979-07-25

Family

ID=5960951

Family Applications (1)

Application Number Title Priority Date Filing Date
IL50817A IL50817A (en) 1975-11-05 1976-11-02 Isobutyl methyl-1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridine dicarboxylate,its preparation and pharmaceutical compositions containing it

Country Status (27)

Country Link
JP (1) JPS5259161A (en)
AT (1) AT352129B (en)
AU (1) AU498964B2 (en)
BE (1) BE847968A (en)
BG (6) BG24805A3 (en)
CA (1) CA1085406A (en)
CH (2) CH623038A5 (en)
CS (1) CS200499B2 (en)
DE (1) DE2549568C3 (en)
DK (1) DK146762C (en)
ES (2) ES452986A1 (en)
FI (1) FI60704C (en)
FR (1) FR2330395A1 (en)
GB (1) GB1516793A (en)
GR (1) GR61241B (en)
HK (1) HK12681A (en)
IE (1) IE43984B1 (en)
IL (1) IL50817A (en)
LU (2) LU88275I2 (en)
NL (2) NL175915C (en)
NO (1) NO145574C (en)
NZ (1) NZ182502A (en)
PL (2) PL106084B1 (en)
PT (1) PT65797B (en)
RO (1) RO70295A (en)
SE (1) SE423542B (en)
ZA (1) ZA766622B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146630A (en) * 1976-11-12 1979-03-27 Boehringer Mannheim Gmbh Blood pressure lowering and adrenergic β-receptor inhibiting 3-(4-phenoxymethylpiperidino)-propyl-phenyl ethers
JPS55301A (en) * 1978-02-14 1980-01-05 Yamanouchi Pharmaceut Co Ltd 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation
DE3212736A1 (en) * 1982-04-06 1983-10-13 Bayer Ag, 5090 Leverkusen USE OF DIHYDROPYRIDINES IN MEDICINAL PRODUCTS WITH SALIDIURETIC EFFECT
DE3222367A1 (en) * 1982-06-15 1983-12-15 Bayer Ag, 5090 Leverkusen Use of 1,4-dihydropyridines in antiarteriosclerotics and preparation thereof
JPS5982192U (en) * 1982-11-27 1984-06-02 エムケ−精工株式会社 door
DE3312216A1 (en) * 1983-04-05 1984-10-11 Bayer Ag, 5090 Leverkusen METHOD FOR PRODUCING SYMMETRIC 1,4-DIHYDROPYRIDINE CARBONIC ACID ESTERS
DE3312283A1 (en) * 1983-04-05 1984-10-18 Bayer Ag, 5090 Leverkusen METHOD FOR PRODUCING UNBALANCED 1,4-DIHYDROPYRIDINE CARBONIC ACID ESTERS
US4794111A (en) * 1984-05-23 1988-12-27 Bayer Aktiengesellschaft Dihydropyridine preparations containing β-blockers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (en) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Asymmetrical 1,4-dihydropyridine-33-dicarboxylic acid esters, process for their preparation and their use as pharmaceuticals

Also Published As

Publication number Publication date
BE847968A (en) 1977-05-04
LU76133A1 (en) 1977-06-02
ZA766622B (en) 1977-10-26
NL930035I2 (en) 1993-10-01
FI763160A (en) 1977-05-06
DE2549568C3 (en) 1981-10-29
RO70295A (en) 1981-08-17
BG24803A3 (en) 1978-05-12
DK146762C (en) 1984-06-12
AT352129B (en) 1979-09-10
FR2330395A1 (en) 1977-06-03
BG24804A3 (en) 1978-05-12
IE43984B1 (en) 1981-07-15
DE2549568B2 (en) 1980-08-21
BG25079A3 (en) 1978-07-12
NO145574B (en) 1982-01-11
AU498964B2 (en) 1979-03-29
PL105940B1 (en) 1979-11-30
FR2330395B1 (en) 1978-12-22
NZ182502A (en) 1978-07-28
DK498476A (en) 1977-05-06
NO763608L (en) 1977-05-06
CH623038A5 (en) 1981-05-15
IL50817A (en) 1979-07-25
SE7612308L (en) 1977-05-06
FI60704B (en) 1981-11-30
PT65797A (en) 1976-12-01
NL175915C (en) 1985-01-16
ES452986A1 (en) 1977-12-16
SE423542B (en) 1982-05-10
DK146762B (en) 1983-12-27
ES463166A1 (en) 1978-07-16
DE2549568A1 (en) 1977-05-18
JPS5259161A (en) 1977-05-16
BG24668A3 (en) 1978-04-12
NL7612198A (en) 1977-05-09
PL106084B1 (en) 1979-11-30
CA1085406A (en) 1980-09-09
GB1516793A (en) 1978-07-05
FI60704C (en) 1982-03-10
NL930035I1 (en) 1993-08-02
HK12681A (en) 1981-04-10
GR61241B (en) 1978-10-12
ATA814276A (en) 1979-02-15
BG24805A3 (en) 1978-05-12
AU1935876A (en) 1978-05-11
JPS5647185B2 (en) 1981-11-07
PT65797B (en) 1978-05-12
CH622779A5 (en) 1981-04-30
NO145574C (en) 1982-04-21
LU88275I2 (en) 1994-02-03
IE43984L (en) 1977-05-05
BG25078A3 (en) 1978-07-12
CS200499B2 (en) 1980-09-15

Similar Documents

Publication Publication Date Title
IL49095A0 (en) 1,4-dihydropyridine-3,5-di-carboxylic acid aralkyl esters,their preparation and pharmaceutical compositions containing them
IL57030A0 (en) Pharmaceutical compositions containing a certain 1,4-dihydropyridine derivative
IL53639A (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
IL49204A0 (en) N-(4-piperidinyl)-n-phenylamides and-carbamates,their preparation and pharmaceutical compositions containing them
IL49911A (en) 5-benzoyl-pyrrole-2-acetic acid derivatives, their preparation and pharmaceutical compositions containing them
KE3593A (en) A 1,4-dihydropyridine derivative its preparation and pharmaceutical compositions containing it
IL52127A0 (en) Novel phosphonous acid derivatives their preparation and pharmaceutical compositions containing them
IL45233A (en) Alkoxyalkyl-1,4-dihydropyridine-3,5-dicarboxylic acid diester derivatives,their preparation and pharmaceutical compositions containing them
IL54948A (en) 2,1,3-benzoxadiazolyl(or benzthiadiazolyl)-4-(1,4-dihydropyridine)derivatives,their preparation and pharmaceutical compositions containing them
IL47413A0 (en) New 1,4-dihydropyridines,their manufacture and pharmaceutical compositions containing them
IL49447A0 (en) Novel lysergic acid amides,their preparation and pharmaceutical compositions containing them
IL50817A0 (en) A 1,4-dihydropyridine-3,5-dicarboxylic acid di-ester derivative,its preparation and pharmaceutical compositions containing it
IL50507A0 (en) Phenoxyalkylcarboxylic acid derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL52433A0 (en) A novel 2-phenylimino-imidazolidine derivative and salts thereof their preparation and pharmaceutical compositions containing them
IL50522A0 (en) Novel n-aryl-n-(4-piperidinyl)-arylacetamides their preparation and pharmaceutical compositions containing them
IL48360A0 (en) Pharmaceutical compositions comprising a certain 1,3-bischromonyloxypropane derivative
HK13285A (en) Pharmaceutical compositions containing immunestimulating n-substituted aziridine-2-carboxylic acid derivatives
IL52547A0 (en) A novel n-pyrrolidylmethyl-benzamide derivative and its salts their preparation and pharmaceutical compositions containing them
GB1555679A (en) Dichlorophenoxy acetic acid derrivative and pharmaceutical compositions containing it
NZ180863A (en) 3,5-bisoxygenated 2-(w-halo-3-oxygenated-1-alkenyl)-cyclopentane-1-heptanoic acid derivatives and pharmaceutical compositions
IL46622A0 (en) A novel 4,5-azimidobenzamide derivative and its salts,their preparation and pharmaceutical compositions containing them
IL48230A (en) Pharmaceutical compositions containing 4-(6-alkoxy-2-naphthyl)-butyric acid derivatives
IL49291A0 (en) New pharmaceutical compositions containing a pteridine derivative
GB2021570B (en) 1,6- dimethyl - 3,4 - dimethyld - mannitol a process for its preparation and pharmaceutical compositions containing it
IL49698A0 (en) Pharmaceutical compositions comprising a certain 1-phenoxy-2-aminopropane derivative